2025-04-01 13:01:51
Latest Post
Emcutix and WiQo Sign Exclusive Licensing Partnership to Revolutionize Derma-cosmetic Treatments in India
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Pantoprazole Sodium for Injection, 40 mg/vial - Single-Dose Vial
Man Industries monetizes its subsidiary's non-core asset in Prime Nerul Location, Navi Mumbai valued at ~₹720 Crores
InterGlobe Foundation and IndiGoReach organise 'My City My Heritage' Walk, showcasing Chhatrapati Sambhajinagar's Cultural Heritage
Relaxo Footwears Ltd honoured with SDG Achievers Award 2023-24 for Quality Education
Stock Report
Kiran Vyapar Ltd consolidated Q4FY24 PAT falls QOQ to Rs. 5.48 crore
Posted On : 2024-05-15 18:54:40( TIMEZONE : IST )
Kiran Vyapar Ltd has reported Consolidated financial results for the period ended March 31, 2024.
Financial Results (Q4 FY2024) - QoQ Comparison
The company has reported total income of Rs. 24.4529 crores during the period ended March 31, 2024 as compared to Rs. 30.4311 crores during the period ended December 31, 2023.
The company has posted net profit / (loss) of Rs. 5.4876 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs. 13.5022 crores for the period ended December 31, 2023.
The company has reported EPS of Rs. 1.93 for the period ended March 31, 2024 as compared to Rs. 4.95 for the period ended December 31, 2023.
| Financials | Q4 FY2024 | Q3 FY2024 | % Change |
| Total Income | ₹24.4529 crs | ₹30.4311 crs |  -19.65% |
| Net Profit | ₹5.4876 crs | ₹13.5022 crs | -59.36% |
| EPS | ₹1.93 | ₹4.95 | -61.01% |
Financial Results (Q4 FY2024) - YoY Comparison
The company has reported total income of Rs.24.4529 crores during the period ended March 31, 2024 as compared to Rs.20.7821 crores during the period ended March 31, 2023.
The company has posted net profit / (loss) of Rs.5.4876 crores for the period ended March 31, 2024 as against net profit / (loss) of Rs.-1.7338 crores for the period ended March 31, 2023.
The company has reported EPS of Rs.1.93 for the period ended March 31, 2024 as compared to Rs.-0.66 for the period ended March 31, 2023.
| Financials | Q4 FY2024 | Q4 FY2023 | % Change |
| Total Income | ₹24.4529 crs | ₹20.7821 crs |  17.66% |
| Net Profit | ₹5.4876 crs | ₹-1.7338 crs | 416.51% |
| EPS | ₹1.93 | ₹-0.66 | 392.42% |
Financial Results (Year Ended FY2024) - YoY Comparison
The company has reported total income of Rs.92.9974 crores during the Financial Year ended March 31, 2024 as compared to Rs.67.8744 crores during the Financial Year ended March 31, 2023.
The company has posted net profit / (loss) of Rs.52.1314 crores for the Financial Year ended March 31, 2024 as against net profit / (loss) of Rs.38.8274 crores for the Financial Year ended March 31, 2023.
The company has reported EPS of Rs.19.12 for the Financial Year ended March 31, 2024 as compared to Rs.14.28 for the Financial Year ended March 31, 2023.
| Financials | Year Ended FY2024 | Year Ended FY2023 | % Change |
| Total Income | ₹92.9974 crs | ₹67.8744 crs | 37.01% |
| Net Profit | ₹52.1314 crs | ₹38.8274 crs | 34.26% |
| EPS | ₹19.12 | ₹14.28 | 33.89% |
Shares of Kiran Vyapar Ltd was last trading in BSE at Rs. 177.90 as compared to the previous close of Rs. 175.05. The total number of shares traded during the day was 5233 in over 52 trades.
The stock hit an intraday high of Rs. 181.00 and intraday low of 174.20. The net turnover during the day was Rs. 924388.00.
